Serum triglycerides and risk of cardiovascular disease
Authors:
- J. de GraafJGJ. de Graaf
- A.F. StalenhoefASA.F. Stalenhoef
- 1 May 2012
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1821 (5) , 867-875
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterolAmerican Heart Journal, 2011
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysisThe Lancet, 2010
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studiesThe Lancet, 2010
- Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: The Three-City StudyAtherosclerosis, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002JAMA, 2005